N,N-DIMETHYL-3,3-DIPHENYL-1-METHYLALLYLAMINE

CC(C=C(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C

InChIKey=QZWMYBWMOFESDA-UHFFFAOYSA-N

InChI=1S/C18H21N/c1-15(19(2)3)14-18(16-10-6-4-7-11-16)17-12-8-5-9-13-17/h4-15H,1-3H3

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

PubMed

Title	Date	PubMed
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.	1988	3203014
Premedication for day-case surgery: double-blind comparison of ketobemidone + dimethylaminodiphenylbuten (A-29) and morphine + scopolamine.	1986-10	3811793
5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats.	1985-09	2865865
Histamine release from human basophils and isolated rat mast cells induced by ketobemidone, pethidine and the spasmolytic A29.	1982-01	6175179
Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.	1981-02	7215421

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:25:41 GMT 2025` Edited by `admin` on `Mon Mar 31 23:25:41 GMT 2025`
Record UNII	A6FGC19UYP
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

N,N-DIMETHYL-3,3-DIPHENYL-1-METHYLALLYLAMINE

Systematic Name

English

A-29 LUNDBECK

Preferred Name

English

N,N,1-TRIMETHYL-3,3-DIPHENYLALLYLAMINE

Systematic Name

English

3-BUTEN-2-AMINE, N,N-DIMETHYL-4,4-DIPHENYL-

Systematic Name

English

ALLYLAMINE, N,N,1-TRIMETHYL-3,3-DIPHENYL-

Systematic Name

English

Code System Code Type Description

SMS_ID

100000138721